Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Colorectal Neoplasms 2Tongue Neoplasms 1Sleep Wake Disorders 1Lymphoid Interstitial Pneumonia 1Hematologic Neoplasms 1

Interventions

Bevacizumab 234Fluorouracil 220Oxaliplatin 216Irinotecan 215Leucovorin 199Capecitabine 153Cetuximab 146Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15Biopsy 15apatinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Phototherapy × Clear all
NCT00083785 2007-04-11

Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Light Sciences LLC

Phase 2 Completed
25 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00068068 2006-09-19

Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases

Light Sciences LLC

Phase 2 Completed
25 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡